# BREO ELLIPTA
> **NDA204275** · New Drug Application · Sponsor: GLAXO GRP LTD · Approved 2013-05-10
## Drug
- **FDA Application Number:** NDA204275
- **Application type:** New Drug Application
- **Brand name:** BREO ELLIPTA
- **Generic name:** FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE
- **Active ingredients:** FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** GLAXO GRP LTD
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 2013-05-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204275)
---
*MORVS · CC0 1.0*